Frontier Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.6M | Buy |
103,003
+583
| +0.6% | +$190K | 0.31% | 133 |
|
|
2025
Q1 | $27.7M | Sell |
102,420
-2,298
| -2% | -$621K | 0.3% | 126 |
|
|
2024
Q4 | $24.6M | Sell |
104,718
-6,513
| -6% | -$1.53M | 0.23% | 155 |
|
|
2024
Q3 | $30.6M | Sell |
111,231
-57,211
| -34% | -$15.7M | 0.29% | 139 |
|
|
2024
Q2 | $40.9M | Buy |
+168,442
| New | +$40.9M | 0.41% | 97 |
|
|
2021
Q3 | – | Sell |
-45,822
| Closed | -$7.77M | – | 282 |
|
|
2021
Q2 | $7.77M | Buy |
+45,822
| New | +$7.77M | 0.06% | 249 |
|
|
2021
Q1 | – | Sell |
-4,746
| Closed | -$617K | – | 278 |
|
|
2020
Q4 | $617K | Hold |
4,746
| – | – | ﹤0.01% | 281 |
|
|
2020
Q3 | $691K | Sell |
4,746
-104
| -2% | -$15.1K | 0.01% | 287 |
|
|
2020
Q2 | $718K | Sell |
4,850
-34,187
| -88% | -$5.06M | 0.01% | 289 |
|
|
2020
Q1 | $4.25M | Sell |
39,037
-12,447
| -24% | -$1.35M | 0.05% | 245 |
|
|
2019
Q4 | $5.93M | Sell |
51,484
-41,885
| -45% | -$4.82M | 0.04% | 245 |
|
|
2019
Q3 | $7.51M | Buy |
93,369
+18,680
| +25% | +$1.5M | 0.06% | 240 |
|
|
2019
Q2 | $5.42M | Buy |
74,689
+6,563
| +10% | +$476K | 0.04% | 256 |
|
|
2019
Q1 | $6.37M | Sell |
68,126
-129,743
| -66% | -$12.1M | 0.05% | 254 |
|
|
2018
Q4 | $14.4M | Buy |
197,869
+191,629
| +3,071% | +$14M | 0.12% | 204 |
|
|
2018
Q3 | $546K | Sell |
6,240
-29,960
| -83% | -$2.62M | ﹤0.01% | 285 |
|
|
2018
Q2 | $3.57M | Buy |
36,200
+9,164
| +34% | +$902K | 0.03% | 276 |
|
|
2018
Q1 | $3.22M | Sell |
27,036
-6,645
| -20% | -$791K | 0.02% | 268 |
|
|
2017
Q4 | $4.28M | Sell |
33,681
-50,820
| -60% | -$6.46M | 0.03% | 267 |
|
|
2017
Q3 | $9.93M | Sell |
84,501
-32,421
| -28% | -$3.81M | 0.07% | 236 |
|
|
2017
Q2 | $9.33M | Sell |
116,922
-79,410
| -40% | -$6.33M | 0.07% | 242 |
|
|
2017
Q1 | $10.1M | Sell |
196,332
-40,603
| -17% | -$2.08M | 0.07% | 240 |
|
|
2016
Q4 | $8.87M | Buy |
+236,935
| New | +$8.87M | 0.07% | 242 |
|
|
2015
Q4 | – | Sell |
-212,682
| Closed | -$17.1M | – | 353 |
|
|
2015
Q3 | $17.1M | Buy |
+212,682
| New | +$17.1M | 0.14% | 208 |
|